Your browser doesn't support javascript.
loading
Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.
Tonyan, Ziravard N; Barbitoff, Yury A; Nasykhova, Yulia A; Danilova, Maria M; Kozyulina, Polina Y; Mikhailova, Anastasiia A; Bulgakova, Olga L; Vlasova, Margarita E; Golovkin, Nikita V; Glotov, Andrey S.
Afiliação
  • Tonyan ZN; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Barbitoff YA; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Nasykhova YA; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Danilova MM; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Kozyulina PY; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Mikhailova AA; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Bulgakova OL; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
  • Vlasova ME; St. Martyr George City Hospital, 194354 St. Petersburg, Russia.
  • Golovkin NV; St. Martyr George City Hospital, 194354 St. Petersburg, Russia.
  • Glotov AS; Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia.
Int J Mol Sci ; 24(24)2023 Dec 12.
Article em En | MEDLINE | ID: mdl-38139235
ABSTRACT
Type 2 diabetes mellitus (T2D) is a chronic metabolic disease characterized by insulin resistance and ß-cell dysfunction and leading to many micro- and macrovascular complications. In this study we analyzed the circulating miRNA expression profiles in plasma samples from 44 patients with T2D and 22 healthy individuals using next generation sequencing and detected 229 differentially expressed miRNAs. An increased level of miR-5588-5p, miR-125b-2-3p, miR-1284, and a reduced level of miR-496 in T2D patients was verified. We also compared the expression landscapes in the same group of patients depending on body mass index and identified differential expression of miR-144-3p and miR-99a-5p in obese individuals. Identification and functional analysis of putative target genes was performed for miR-5588-5p, miR-125b-2-3p, miR-1284, and miR-496, showing chromatin modifying enzymes and apoptotic genes being among the significantly enriched pathways.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / MicroRNAs / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / MicroRNAs / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article